Marshall Wace, LLP Fonar Corp Transaction History

Marshall Wace, LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$14.53 - $19.1 $393,152 - $516,807	-27,058 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$14.55 - $18.6 $31,617 - $40,417	-2,173 Reduced 7.43%	27,058 $405,000
Q3 2021 Nov 15, 2021	SELL	$15.44 - $17.77 $30,818 - $35,468	-1,996 Reduced 6.39%	29,231 $452,000
Q2 2021 Aug 13, 2021	BUY	$16.58 - $19.0 $517,743 - $593,313	31,227 New	31,227 $552,000
Q4 2019 Feb 14, 2020	SELL	$19.23 - $20.78 $185,434 - $200,381	-9,643 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$20.51 - $25.07 $288,944 - $353,186	-14,088 Reduced 59.37%	9,643 $199,000
Q2 2019 Aug 14, 2019	BUY	$19.2 - $22.8 $44,716 - $53,101	2,329 Added 10.88%	23,731 $510,000
Q1 2019 May 14, 2019	BUY	$20.07 - $23.69 $94,349 - $111,366	4,701 Added 28.15%	21,402 $438,000
Q4 2018 Feb 14, 2019	BUY	$20.07 - $25.33 $335,189 - $423,036	16,701 New	16,701 $338,000

3.09M

Ticker FONR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 6,554,210
Market Cap $101M
Description
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic servi...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.